Diaxxo AG

Diaxxo is a startup originated at ETH Zürich, where in the past 4 years we have developed and prototyped an innovative Point-of-Care Polymerase Chain Reaction (PCR) device. Our vision is to bring the power of molecular diagnostics to every doctor’s office and clinic, thanks also to our new pre-loaded PCR test kits that allow for simpler and faster sample preparation steps. During 2020 our devices have been used by more than 250 users for the rapid detection of COVID-19 in a field study that was run at ETH Zürich, and our systems are currently being tested also at the Swiss Tropical and Public Health Institute (Swiss TPH) and at the Tierspital Zürich. Several medical doctors have already expressed interest in our technology, and we are now working towards the IVDR certification.